Latest Annual Report
Filed: 2026-02-20
Key Insights
- The company reported a significant increase in research and development expenses, indicating a focus on expanding its product pipeline and driving future growth.
- AbbVie's property, plant, and equipment have seen steady growth, suggesting ongoing investments in manufacturing and infrastructure to support its operations.
- The company has taken on additional long-term debt, which could impact its financial flexibility and cost of capital going forward.